Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,134 | 257 | 98.9% |
| Education | $146.93 | 22 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,256 | 36 | $0 (2023) |
| Novo Nordisk Inc | $1,293 | 40 | $0 (2024) |
| Lilly USA, LLC | $1,152 | 37 | $0 (2023) |
| Amarin Pharma Inc. | $979.35 | 25 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $925.38 | 21 | $0 (2024) |
| ABBVIE INC. | $882.50 | 8 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $655.97 | 25 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $601.97 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $509.02 | 13 | $0 (2018) |
| Amgen Inc. | $496.41 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.65 | 7 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($149.01) |
| 2023 | $418.79 | 17 | Lilly USA, LLC ($95.07) |
| 2022 | $679.23 | 11 | AstraZeneca Pharmaceuticals LP ($365.98) |
| 2021 | $1,157 | 11 | AstraZeneca Pharmaceuticals LP ($304.01) |
| 2020 | $116.40 | 1 | Amarin Pharma Inc. ($116.40) |
| 2019 | $2,646 | 44 | AstraZeneca Pharmaceuticals LP ($347.63) |
| 2018 | $3,424 | 84 | AstraZeneca Pharmaceuticals LP ($463.26) |
| 2017 | $4,364 | 104 | AstraZeneca Pharmaceuticals LP ($732.81) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $144.57 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $149.01 | General |
| Category: PSYCHIATRY | ||||||
| 04/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $93.06 | General |
| Category: Opioid Use Disorder | ||||||
| 04/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: DIABETES | ||||||
| 01/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: VACCINES | ||||||
| 11/02/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Diabetes | ||||||
| 09/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Inflammation | ||||||
| 08/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Oncology | ||||||
| 06/14/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Neuroscience | ||||||
| 05/31/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Obesity | ||||||
| 04/12/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/07/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $91.45 | General |
| Category: NEUROLOGY | ||||||
| 03/16/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Neuroscience | ||||||
| 03/07/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: PAIN | ||||||
| 02/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Inflammation | ||||||
| 01/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 179 | 242 | $70,252 | $22,588 |
| 2022 | 4 | 279 | 404 | $92,018 | $31,457 |
| 2021 | 9 | 530 | 821 | $160,653 | $59,461 |
| 2020 | 12 | 593 | 839 | $144,516 | $40,943 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 131 | $38,336 | $11,916 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $11,026 | $4,477 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $10,152 | $2,809 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,588 | $1,707 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 25 | $5,150 | $1,678 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 332 | $73,774 | $24,593 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $6,692 | $3,692 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $8,816 | $2,107 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 18 | $2,736 | $1,066 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 306 | 592 | $131,424 | $47,859 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $7,648 | $4,383 | 57.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $10,752 | $2,533 | 23.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 40 | $6,080 | $2,392 | 39.3% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 38 | 38 | $2,280 | $1,138 | 49.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $1,330 | $662.34 | 49.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 20 | 20 | $760.00 | $384.00 | 50.5% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 15 | 16 | $288.00 | $65.52 | 22.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 13 | $91.00 | $45.24 | 49.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 255 | 464 | $103,008 | $29,598 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 89 | $13,528 | $4,313 | 31.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 55 | 59 | $10,495 | $2,404 | 22.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 55 | 56 | $5,782 | $1,386 | 24.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $3,536 | $982.24 | 27.8% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 19 | 19 | $2,964 | $561.50 | 18.9% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 40 | 45 | $2,001 | $480.84 | 24.0% |
About Dr. Binh Tran, MD
Dr. Binh Tran, MD is a Family Medicine healthcare provider based in N Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801998166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Binh Tran, MD has received a total of $13,281 in payments from pharmaceutical and medical device companies, with $475.65 received in 2024. These payments were reported across 279 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($13,134).
As a Medicare-enrolled provider, Tran has provided services to 1,581 Medicare beneficiaries, totaling 2,306 services with total Medicare billing of $154,449. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location N Las Vegas, NV
- Active Since 09/05/2006
- Last Updated 10/20/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801998166
Products in Payments
- FARXIGA (Drug) $1,416
- JARDIANCE (Drug) $1,026
- Vascepa (Drug) $979.35
- XARELTO (Drug) $456.60
- Tresiba (Drug) $381.04
- Victoza (Drug) $337.71
- BREZTRI (Drug) $319.91
- Ozempic (Drug) $283.98
- HUMULIN (Drug) $247.01
- AFREZZA (Drug) $245.55
- Livalo (Drug) $243.88
- TRULICITY (Drug) $221.87
- EUCRISA (Drug) $211.53
- Aimovig (Biological) $208.60
- INVOKANA (Drug) $199.37
- VRAYLAR (Drug) $194.23
- TRELEGY ELLIPTA (Drug) $153.75
- BYDUREON (Drug) $151.18
- CAPLYTA (Drug) $149.01
- MOUNJARO (Drug) $148.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in N Las Vegas
William Jacks, Md, MD
Family Medicine — Payments: $16,485
Jeaniene Talley, Md, MD
Family Medicine — Payments: $3,204
Lara Wenner, Md, MD
Family Medicine — Payments: $1,991
Mohammad Atif, Md, MD
Family Medicine — Payments: $1,851
Peter Asafo-Adjei, M.d, M.D
Family Medicine — Payments: $749.28
Dr. Zephyrene Villaluz, M.d, M.D
Family Medicine — Payments: $187.91